NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy vs chemo: new hope for bladder cancer patients?
Disease control Recruiting nowThis phase II trial compares two treatments for high-grade T1 bladder cancer that hasn't spread. One group gets the immunotherapy drug pembrolizumab plus radiation, while the other gets standard chemotherapy (cisplatin, gemcitabine, 5-fluorouracil, or mitomycin-C) plus radiation.…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
Laser-Activated drug targets bladder tumors in early trial
Disease control Recruiting nowThis early-stage trial is testing a new drug called belzupacap sarotalocan (AU-011) for people with non-muscle-invasive bladder cancer. The drug is injected directly into the tumor, sometimes with a laser to activate it. The main goal is to see if this approach is safe and feasib…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
Could a single, smarter surgery spare bladder cancer patients a second operation?
Disease control Recruiting nowThis study compares two approaches for treating non-muscle invasive bladder cancer. The standard approach uses two surgeries: one to remove the tumor and a second to check for leftover cancer. The new approach uses a single, enhanced surgery with a special dye and light to better…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE4 • Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
New drug combo aims to control bladder cancer when standard therapy fails
Disease control Recruiting nowThis study tests two drugs, durvalumab and monalizumab, given together to people with a type of bladder cancer that has not gotten better with standard treatment. The goal is to see if the combination can make the cancer disappear or stop it from growing. About 60 adults will tak…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: John Sfakianos • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New DNA test may catch bladder cancer that scopes miss
Diagnosis Recruiting nowThis study is testing whether a combined blood and urine DNA test can detect muscle-invasive bladder cancer that standard scoping exams might miss before bladder removal surgery. About 92 adults scheduled for cystectomy will provide samples to see if the test accurately predicts …
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Sponsor: Fox Chase Cancer Center • Aim: Diagnosis
Last updated Jun 08, 2026 13:04 UTC
-
Could a prostate drug help fight bladder cancer?
Knowledge-focused Recruiting nowThis early-stage trial is testing whether bicalutamide, a drug typically used for prostate cancer, can change a protein linked to bladder cancer growth. Researchers will compare men with non-muscle invasive bladder cancer who take the drug to those who don't. The goal is to see i…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:06 UTC